The use of hydroxychloroquine as a systemic treatment in erosive lichen planus of the vulva and vagina

H A B Vermeer; H Rashid; M D Esajas; J M Oldhoff; B Horváth

doi:10.1111/bjd.19870

The use of hydroxychloroquine as a systemic treatment in erosive lichen planus of the vulva and vagina

H A B Vermeer, H Rashid, M D Esajas, J M Oldhoff^*, B Horváth

^*Corresponding author for this work

Translational Immunology Groningen (TRIGR)

Research output: Contribution to journal › Letter › Academic › peer-review

12 Citations (Scopus)

188 Downloads (Pure)

Abstract

Erosive lichen planus affecting the vulva and vagina (ELPV) is a rare inflammatory skin disease, presenting with painful erosions and severe scarring.1 The disease course is persistent and often refractory to treatment: up to 45% patients do not experience remission with topical treatments, while evidence for systemic treatments remains scarce.2 Hydroxychloroquine (HCQ) is frequently used in daily practice as a first choice systemic therapy.3 However, little evidence is available on HCQ for ELPV.2 The aim of this study was to analyse the effectiveness and safety of HCQ in ELPV.

Original language	English
Number of pages	2
Journal	The British journal of dermatology
Early online date	6-Feb-2021
DOIs	https://doi.org/10.1111/bjd.19870
Publication status	Published - 23-Mar-2021

Access to Document

10.1111/bjd.19870Licence: CC BY-NC-ND

The use of hydroxychloroquine as a systemic treatment in erosive lichen planus of the vulva and vaginaFinal publisher's version, 107 KBLicence: CC BY-NC-ND

Handle.net

Persistent link

Cite this

@article{af3a1d4ca50748458ff97b1c2d3b06a8,

title = "The use of hydroxychloroquine as a systemic treatment in erosive lichen planus of the vulva and vagina",

abstract = "Erosive lichen planus affecting the vulva and vagina (ELPV) is a rare inflammatory skin disease, presenting with painful erosions and severe scarring.1 The disease course is persistent and often refractory to treatment: up to 45% patients do not experience remission with topical treatments, while evidence for systemic treatments remains scarce.2 Hydroxychloroquine (HCQ) is frequently used in daily practice as a first choice systemic therapy.3 However, little evidence is available on HCQ for ELPV.2 The aim of this study was to analyse the effectiveness and safety of HCQ in ELPV.",

author = "Vermeer, {H A B} and H Rashid and Esajas, {M D} and Oldhoff, {J M} and B Horv{\'a}th",

year = "2021",

month = mar,

day = "23",

doi = "10.1111/bjd.19870",

language = "English",

journal = "The British journal of dermatology",

issn = "0007-0963",

publisher = "Wiley",

}

TY - JOUR

T1 - The use of hydroxychloroquine as a systemic treatment in erosive lichen planus of the vulva and vagina

AU - Vermeer, H A B

AU - Rashid, H

AU - Esajas, M D

AU - Oldhoff, J M

AU - Horváth, B

PY - 2021/3/23

Y1 - 2021/3/23

N2 - Erosive lichen planus affecting the vulva and vagina (ELPV) is a rare inflammatory skin disease, presenting with painful erosions and severe scarring.1 The disease course is persistent and often refractory to treatment: up to 45% patients do not experience remission with topical treatments, while evidence for systemic treatments remains scarce.2 Hydroxychloroquine (HCQ) is frequently used in daily practice as a first choice systemic therapy.3 However, little evidence is available on HCQ for ELPV.2 The aim of this study was to analyse the effectiveness and safety of HCQ in ELPV.

AB - Erosive lichen planus affecting the vulva and vagina (ELPV) is a rare inflammatory skin disease, presenting with painful erosions and severe scarring.1 The disease course is persistent and often refractory to treatment: up to 45% patients do not experience remission with topical treatments, while evidence for systemic treatments remains scarce.2 Hydroxychloroquine (HCQ) is frequently used in daily practice as a first choice systemic therapy.3 However, little evidence is available on HCQ for ELPV.2 The aim of this study was to analyse the effectiveness and safety of HCQ in ELPV.

U2 - 10.1111/bjd.19870

DO - 10.1111/bjd.19870

M3 - Letter

C2 - 33548058

SN - 0007-0963

JO - The British journal of dermatology

JF - The British journal of dermatology

ER -

The use of hydroxychloroquine as a systemic treatment in erosive lichen planus of the vulva and vagina

Abstract

Access to Document

Handle.net

Fingerprint

Cite this